Indegene vs Peers
- Market cap
- ₹14,576 crore
- P/E
- 36.4
- P/B
- 4.64
- ROE
- 13.9%
- Dividend yield
- 0.37%
Indegene ranks 1st by market capitalisation among 4 Healthcare Research, Analytics & Technology companies tracked by ATS. Its largest peers are Syngene International, Suven Life Sciences and Bilcare. Its P/E of 36.4 compares with a peer median of 28.8.
Indegene vs Healthcare Research, Analytics & Technology peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Indegene | 606.00 | +1.63% | 14,576 | 36.4 | 4.64 | 13.9% | +22.0% |
| Syngene International | 360.10 | -0.85% | 14,468 | 65.5 | 2.99 | 6.6% | +12.5% |
| Suven Life Sciences | 307.05 | -0.68% | 8,098 | 22.5 | 13.69 | -78.8% | +12.5% |
| Bilcare | 94.75 | +1.99% | 223 | 28.8 | 1.13 | 0.8% | +12.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 7 October 2026. How this data is compiled.
Indegene peer comparison — frequently asked questions
Who are Indegene's competitors?
Indegene's listed peers in Healthcare Research, Analytics & Technology include Syngene International, Suven Life Sciences and Bilcare, ranked here by market capitalisation.
How does Indegene's P/E compare with its peers?
Indegene trades at a P/E of 36.4, against a median of 28.8 across the 3 Healthcare Research, Analytics & Technology peers shown.
Which is the largest company among Indegene's peers?
By market capitalisation, the largest company in the group is Syngene International at ₹14,468 crore, against ₹14,576 crore for Indegene.
Same Data For Peers
Trade Indegene With ATS
Track INDGN live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.